H
HoyleCohen Portfolio holdings
AUM
$1.32B
This Quarter Return
+9.94%
1 Year Return
+27.05%
3 Year Return
+46.09%
5 Year Return
+145.64%
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(+7.1%)
Cap. Flow
-$4.79M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
287
New
16
Increased
111
Reduced
103
Closed
5
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$3.13M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$2.96M |
| 3 |
Schwab U.S Small- Cap ETF
SCHA
|
$1.79M |
| 4 |
Invesco QQQ Trust
QQQ
|
$1.46M |
| 5 |
Novo Nordisk
NVO
|
$1.38M |
Top Sells
| 1 |
Apple
AAPL
|
$5.35M |
| 2 |
Bristol-Myers Squibb
BMY
|
$3.87M |
| 3 |
Honeywell
HON
|
$3.48M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$1.88M |
| 5 |
SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
|
$1.45M |
Sector Composition
| 1 | Technology | 24.67% |
| 2 | Financials | 11.09% |
| 3 | Healthcare | 7.57% |
| 4 | Communication Services | 6.46% |
| 5 | Industrials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Warner Bros
WBD
$29.5B
| $97.6K | 0.01% |
11,182
-783
| -7% | -$6.84K |
|
|
IGR
277
CBRE Global Real Estate Income Fund
IGR
$702M
| $53.8K | ﹤0.01% |
+10,000
| New | +$53.8K |
|
278
Standard BioTools
LAB
$493M
| $35.2K | ﹤0.01% |
+13,002
| New | +$35.2K |
|
279
Personalis
PSNL
$430M
| $22.9K | ﹤0.01% |
15,373
| – | – |
|
|
AKTS
280
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $21.6K | ﹤0.01% |
36,502
| – | – |
|
|
VIRX
281
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $14.3K | ﹤0.01% |
14,000
| – | – |
|
|
TCON
282
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $5.59K | ﹤0.01% |
650
| – | – |
|
|
SLGC
283
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-11,714
| Closed | -$29.6K |
|
284
Zscaler
ZS
$42.1B
| – | – |
-906
| Closed | -$201K |
|
285
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-528
| Closed | -$215K |
|
286
Nuveen California Quality Municipal Income Fund
NAC
$1.63B
| – | – |
-12,296
| Closed | -$136K |
|
287
Halozyme
HALO
$8.75B
| – | – |
-8,775
| Closed | -$324K |
|